Linkedin Twitter
Submit RFP
BLOG 

Cardiovascular Clinical Research

Discover the latest updates on cardiovascular clinical research, innovative studies, and exciting conference news. Join us on our journey as we explore the latest discoveries and innovations transforming how we understand and treat cardiovascular diseases.

  • All
  • Careers
  • Fairs
  • Insights
ESC Heart Failure 2023
Fairs

Join Us in Prague for the ESC Heart Failure Meeting

Wiebke Lesch 21. April 2023
Save the dates in your agenda and join us in Prague from 20 to 23 May 2023 for the ESC Heart Failure Association (HFA) annual meeting bringing together scientists, healthcare professionals, and other players from around the world. The world's leading...
Fairs

Connect with Us at HFSA Annual Scientific Meeting 2022

Wiebke Lesch 14. September 2022
SCIRENT, a full-service contract research organization (CRO) specializing in cardiovascular trials, is joining forces with CCS, a US-based cardiovascular clinical research organization, at HFSA Annual Scientific Meeting 2022 in Washington. Come and meet us at booth 228 from September 30, 2022 -...
Fairs

Meet Us at ESC Congress 2022 in Barcelona

Wiebke Lesch 10. August 2022
SCIRENT is excited to participate at the ESC Congress 2022 in Barcelona, which is taking place from 26-29 August 2022. Please book an appointment with our leadership to learn more about our industry-leading cardiovascular research services and patient recruitment capabilities....
SCIRENT is exhibitor at the American Heart Association 2021 Scientific Sessions.
Fairs

Meet Us at AHA 2021

Wiebke Lesch 10. November 2021
10.11.2021. SCIRENT is attending the American Heart Association’s Scientific Sessions, AHA 2021, from November 13-15, 2021 as a proud exhibitor. Visit our booth and connect with us live to learn more about our industry-leading cardiovascular research services, patient recruitment capabilities,...
Careers

SCIRENT Appoints Dr. Maximilian Posch, MD, as Chief Medical Officer

Wiebke Lesch 21. September 2021
BERLIN, Sept. 21, 2021 /PRNewswire/ -- SCIRENT, an international full-service cardiovascular contract research organization (CRO), is proud to appoint Dr. Maximilian Posch as Chief Medical Officer. In his new position, Dr. Posch will be an important driver of SCIRENT's growth...
Berlin Heals' innovative implantable C-MIC device delivers encouraging clinical results in the treatment of heart failure.
Insights

Innovative Medical Device for Heart Failure Treatment Delivers Promising Results

Wiebke Lesch 1. June 2021
Berlin Heals' innovative implantable C-MIC device has demonstrated encouraging clinical results in the treatment of heart failure. They are now published in ESC Heart Failure. The C-MIC is a small implantable device that delivers a minimal constant electrical microcurrent to...
Crisis Management for Rapid Resumption of Cardiovascular Clinical Trials during the COVID-19 pandemic
Insights

Restarting by Design: Agile Crisis Management for Rapid Resumption of Cardiovascular Clinical Trials

Wiebke Lesch 4. May 2021
The entire landscape of hospital-based clinical trials dramatically changed when COVID-19 singlehandedly stopped the global recruitment of ongoing cardiovascular trials. Heart failure clinical trials were already subject to factors such as regional variation in clinical practice, trial implementation, and patient...
SCIRENT Virtual Core Lab
Insights

SCIRENT and Virtonomy Announce Joint Efforts to Advance Use of Virtual Patients in Medical Device Clinical Trials

Wiebke Lesch 14. January 2021
SCIRENT, a full-service contract research organization (CRO) specialized in cardiovascular trials, and Virtonomy, a pioneer in developing data-driven clinical trials using virtual patients, announced today their cooperation on the use of virtual patients in medical device clinical trials. Both companies offer...
Human Heart Illustration
Insights

An Innovative Approach in Treating Heart Failure

Wiebke Lesch 11. December 2020
Global medical technology and innovation company, LivaNova PLC, conducts the large medical device study ANTHEM-HFrEF to evaluate whether autonomic regulation therapy will benefit patients with symptomatic heart failure and reduced ejection fraction. The trial is performed by the US-based CRO...
Insights

SCIRENT Supports Phase IIa Study of BC 007 for the Treatment of Heart Failure

Wiebke Lesch 8. December 2020
Heart failure is one of the most common causes of death in Western society and is becoming increasingly global. Its socio-economic impact is enormous, equivalent to the impact caused by cancer. Although there has been progress in treatment over the...
Insights

COVID-19: Keeping up Trial Safety and Progress

Wiebke Lesch 4. June 2020
The global COVID-19 pandemic has largely impacted the healthcare system and also the conduct of clinical trials. Many sponsors have had to adapt clinical trial operations to the changing conditions of the pandemic, causing major disruptions in trial conduct. Some...
SCIRENT is exhibitor at the American Heart Association 2021 Scientific Sessions.

Meet Us at AHA 2021

Wiebke Lesch 10. November 2021

10.11.2021. SCIRENT is attending the American Heart Association’s Scientific Sessions, AHA 2021, from November 13-15, 2021 as a proud exhibitor. Visit our booth and connect

Weiterlesen »
Clinical Research
and Science
Menu

Thank you for your application.

We will get in touch shortly.

Thank you. Your data was submitted successfully.

We will get in touch shortly.